Hunan Mitochondrial Culture Communication Co., Ltd – Trademark Portfolio
Entity Type: 99
Hunan Mitochondrial Culture Communication Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include FREVIVIM. The owner is based in St.,Changsha , Hunan.
501,building 1,Boya Machinery office
building,Sanxing Zhiye company, Xingsha
St.,Changsha , Hunan 410000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Hunan Mitochondrial Culture Communication Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Hunan Mitochondrial Culture Communication Co., Ltd have?
Hunan Mitochondrial Culture Communication Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Hunan Mitochondrial Culture Communication Co., Ltd file in?
Hunan Mitochondrial Culture Communication Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Hunan Mitochondrial Culture Communication Co., Ltd's most well-known trademarks?
Hunan Mitochondrial Culture Communication Co., Ltd's registered trademark portfolio includes well-known marks such as FREVIVIM. These are among 1 currently registered trademark in the portfolio.
What is Hunan Mitochondrial Culture Communication Co., Ltd's trademark registration success rate?
Hunan Mitochondrial Culture Communication Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.